Hematologic neoplasm (disorder)

Causes of Clonal Blood Cell Disorders study

Year Started: 2007

Blood and related products, including viable cells and nucleic acids from patients with haematological disorders with clonal origins, such as leukaemia, myeloproliferative disorders, myelodysplasia, myeloma, lymphoma and related conditions. Samples collected at diagnosis or before commencing therapy where possible; and at progression of disease if available, in patients of all ages and gender. Samples collected as part of the REC-approved Causes of Clonal Blood Cell Disorders study.



Access:
Open to applicants
Type:
Disease specific
Status:
In progress
Consent restrictions:
No restrictions


Associated Data Type Procurement Timeframe
Biomarker datasets 0 - 3 months
Clinical records 0 - 3 months
Followup records 0 - 3 months
Freezer temperature logs 0 - 3 months
Genomic datasets 0 - 3 months
Pathology records 0 - 3 months
Quality indicators 0 - 3 months
Treatment records 0 - 3 months


Unknown

Data not recorded

3001 - 5000 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
DNA -60°C to -85°C N/A Affected 100%